Literature DB >> 24706899

Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation.

Xuan Li1, Nathan J Marchant, Yavin Shaham.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24706899      PMCID： PMC4000783          DOI： 10.1073/pnas.1403603111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

Review 1.  The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.

Authors:  J G Sutcliffe; L de Lecea
Journal:  J Neurosci Res       Date:  2000-10-15       Impact factor: 4.164

Review 2.  Dopamine, learning and motivation.

Authors:  Roy A Wise
Journal:  Nat Rev Neurosci       Date:  2004-06       Impact factor: 34.870

3.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Neurons containing hypocretin (orexin) project to multiple neuronal systems.

Authors:  C Peyron; D K Tighe; A N van den Pol; L de Lecea; H C Heller; J G Sutcliffe; T S Kilduff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

5.  Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus.

Authors:  C Chavkin; A Goldstein
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

Review 6.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

7.  Orexin (hypocretin) neurons contain dynorphin.

Authors:  T C Chou; C E Lee; J Lu; J K Elmquist; J Hara; J T Willie; C T Beuckmann; R M Chemelli; T Sakurai; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

9.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

10.  Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.

Authors:  John W Muschamp; Jonathan A Hollander; Jennifer L Thompson; George Voren; Linda C Hassinger; Sara Onvani; Theodore M Kamenecka; Stephanie L Borgland; Paul J Kenny; William A Carlezon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205
View more
  8 in total

Review 1.  Functional consequences of neuropeptide and small-molecule co-transmission.

Authors:  Michael P Nusbaum; Dawn M Blitz; Eve Marder
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

2.  The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.

Authors:  Gregory S Parks; Deepti R Warrier; Lars Dittrich; Michael D Schwartz; Jeremiah B Palmerston; Thomas C Neylan; Stephen R Morairty; Thomas S Kilduff
Journal:  Neuropsychopharmacology       Date:  2015-08-20       Impact factor: 7.853

Review 3.  Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.

Authors:  Shi-Bin Li; Jeff R Jones; Luis de Lecea
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

Review 4.  Cell type- and pathway-specific synaptic regulation of orexin neurocircuitry.

Authors:  Jing-Jing Liu; Vincent R Mirabella; Zhiping P Pang
Journal:  Brain Res       Date:  2018-10-05       Impact factor: 3.252

Review 5.  The kappa opioid receptor: from addiction to depression, and back.

Authors:  Laurence Lalanne; Gulebru Ayranci; Brigitte L Kieffer; Pierre-Eric Lutz
Journal:  Front Psychiatry       Date:  2014-12-08       Impact factor: 4.157

Review 6.  Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Front Neurol       Date:  2018-08-28       Impact factor: 4.003

7.  Sleep modulates haematopoiesis and protects against atherosclerosis.

Authors:  Cameron S McAlpine; Máté G Kiss; Sara Rattik; Shun He; Anne Vassalli; Colin Valet; Atsushi Anzai; Christopher T Chan; John E Mindur; Florian Kahles; Wolfram C Poller; Vanessa Frodermann; Ashley M Fenn; Annemijn F Gregory; Lennard Halle; Yoshiko Iwamoto; Friedrich F Hoyer; Christoph J Binder; Peter Libby; Mehdi Tafti; Thomas E Scammell; Matthias Nahrendorf; Filip K Swirski
Journal:  Nature       Date:  2019-02-13       Impact factor: 49.962

Review 8.  Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain.

Authors:  Olga Nosova; Igor Bazov; Victor Karpyak; Mathias Hallberg; Georgy Bakalkin
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.